What smart money is saying about CG Oncology Inc.
CGON
No fund has written a full thesis on CG Oncology Inc. in our archive, but 2 fund letters report a position in it — most recently Clearbridge Global Growth Strategy in December 2025.
Get an email when a fund writes about it
2
Reported positions
2
Bought
0
Sold
3
Letters
Position history
Between Q3 2025 and Q4 2025, 2 fund letters reported a position in CG Oncology Inc. — 2 opened or added to the position.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q4 2025 | 1 | 1 | 0 | 0 |
| Q3 2025 | 1 | 1 | 0 | 0 |
Fund activity · 2 positions · 2 moves
- New positionClearbridge Global Growth StrategyDecember 2025
“In addition to the transactions mentioned above, we added positions in Walmart and PT Unilever in consumer staples, MTU Aero Engines, Ferguson, Eaton and Sandvik in industrials, Ulta Beauty in consumer discretionary, Johnson & Johnson and CG Oncology in health care, Nu Holdings in financials and Amphenol in IT.”
CG Oncology Inc. - New positionClearbridge Small Cap StrategySeptember 2025
“In addition to the transactions listed above, we initiated new positions in CG Oncology, Celcuity and Bicara Therapeutics in the health care sector, Freshpet in the consumer staples sector and Piedmont Realty Trust in the real estate sector.”
CG Oncology Inc.
Also mentioned · 1
These funds discuss CG Oncology Inc. — as a competitor, benchmark or comparable — without disclosing a position in it.
- March 2026
“CG Oncology Inc. is a late-stage clinical biopharmaceutical company focused on developing therapeutics to treat bladder cancer.”
CG Oncology Inc.
Read the letters behind these CG Oncology Inc. positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger